US Supreme Court to hear Bayer’s appeal against weedkiller lawsuits
German group is seeking to end multibillion-dollar litigation alleging its Roundup pesticide causes cancer
Related reading
US Supreme Court appears split on safety labels for Bayer weedkiller Roundup
Case has emerged as one of the biggest ongoing multibillion-dollar corporate tort claims
Bayer’s ambitions boosted by relaxation of EU gene-edited crop rules
German life sciences giant says looser regulations could reshape Europe’s €6bn seed market
Bayer soars on promising trial results for stroke prevention drug
Findings are respite for German conglomerate facing sliding sales of blockbuster drugs and US legal challenges
Merck splits operations to separate oncology from non-cancer drugs
Reshuffle in preparation for 2028 US patent expiry of blockbuster cancer treatment Keytruda
US Supreme Court sides with Bayer over Roundup cancer suits
Bayer, which acquired Roundup in 2018, said the decision is good for science and farmers. The Supreme Court's ruling was met with…
Merck’s record cancer drug sales power earnings growth
Quarterly proceeds from Keytruda top $8bn for first time